reported that 20 of 48 (47.9%) patients with Alzheimer’s disease had anti-BP180 autoantibodies detected by BP180 NC16A ELISA, and the mean titer ± SD was 22.9 ± 20.9 (53). This evidence concerns the gene COL17A1 and early-onset autosomal dominant Alzheimer disease.